Yasushi Sato - Search Results

Year	Number of Results
1970	1
1971	2
2002	6
2003	6
2004	10
2005	8
2006	14
2007	17
2008	15
2009	10
2010	16
2011	22
2012	22
2013	16
2014	19
2015	25
2016	21
2017	13
2018	11
2019	7
2020	17
2021	19
2022	21
2023	23
2024	8

1

Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.

Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Tomonari T, Kawano Y, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: sato y. Eur J Clin Invest. 2024 Apr 18:e14221. doi: 10.1111/eci.14221. Online ahead of print. Eur J Clin Invest. 2024. PMID: 38634705

2

Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.

Sogabe M, Okahisa T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Kawano Y, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: sato y. J Gastroenterol Hepatol. 2024 Feb 29. doi: 10.1111/jgh.16530. Online ahead of print. J Gastroenterol Hepatol. 2024. PMID: 38419514

3

Gastric fundic gland polyposis and cancer development after eradication of Helicobacter pylori in patient with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).

Okamoto K, Kawaguchi T, Kagemoto K, Kida Y, Mitsui Y, Nakamura F, Yoshikawa K, Sogabe M, Sato Y, Shunto J, Bando Y, Shimada M, Takayama T. Okamoto K, et al. Among authors: sato y. Gastric Cancer. 2024 May;27(3):635-640. doi: 10.1007/s10120-024-01473-x. Epub 2024 Feb 26. Gastric Cancer. 2024. PMID: 38407681

4

Author Correction: A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.

Kasai A, Miyoshi J, Sato Y, Okamoto K, Miyamoto H, Kawanaka T, Tonoiso C, Harada M, Goto M, Yoshida T, Haga A, Takayama T. Kasai A, et al. Among authors: sato y. Sci Rep. 2024 Feb 13;14(1):3648. doi: 10.1038/s41598-024-54210-w. Sci Rep. 2024. PMID: 38351243 Free PMC article. No abstract available.

5

[Tolerability and Outcome of Neoadjuvant GS Therapy for Resectable Pancreatic Cancer].

Yamashita M, Shimizu J, Sato Y, Noma T, Hagihara K, Yanagimoto Y, Suzuki Y, Ikenaga M, Kawase T, Imamura H, Akagi K, Iwasawa S, Tomita N. Yamashita M, et al. Among authors: sato y. Gan To Kagaku Ryoho. 2023 Dec;50(13):1411-1413. Gan To Kagaku Ryoho. 2023. PMID: 38303291 Japanese.

6

A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.

Kasai A, Miyoshi J, Sato Y, Okamoto K, Miyamoto H, Kawanaka T, Tonoiso C, Harada M, Goto M, Yoshida T, Haga A, Takayama T. Kasai A, et al. Among authors: sato y. Sci Rep. 2024 Jan 23;14(1):2039. doi: 10.1038/s41598-024-52418-4. Sci Rep. 2024. PMID: 38263395 Free PMC article.

7

Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal study.

Sogabe M, Okahisa T, Kagawa M, Sei M, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: sato y. J Gastroenterol Hepatol. 2024 Apr;39(4):754-761. doi: 10.1111/jgh.16483. Epub 2024 Jan 11. J Gastroenterol Hepatol. 2024. PMID: 38212880

8

Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan.

Nakamura N, Hasebe S, Yamanaka S, Fujii T, Fujibuchi T, Kitani T, Takeuchi K, Sato Y, Shindo Y, Ozaki T, Nishisho T, Tabata M, Yakushijin Y. Nakamura N, et al. Among authors: sato y. Int J Clin Oncol. 2024 Mar;29(3):345-353. doi: 10.1007/s10147-023-02453-4. Epub 2023 Dec 28. Int J Clin Oncol. 2024. PMID: 38155238

9

Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.

Kawaguchi T, Okamoto K, Fujimoto S, Bando M, Wada H, Miyamoto H, Sato Y, Muguruma N, Horimoto K, Takayama T. Kawaguchi T, et al. Among authors: sato y. J Gastroenterol. 2024 Jan;59(1):11-23. doi: 10.1007/s00535-023-02052-0. Epub 2023 Nov 22. J Gastroenterol. 2024. PMID: 37989907

10

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Tomonari T, Tani J, Sato Y, Tanaka H, Tanaka T, Taniguchi T, Kawano Y, Morishita A, Okamoto K, Sogabe M, Miyamoto H, Masaki T, Takayama T. Tomonari T, et al. Among authors: sato y. Cancers (Basel). 2023 Oct 30;15(21):5221. doi: 10.3390/cancers15215221. Cancers (Basel). 2023. PMID: 37958395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

317 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Results by year